| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
36,010,000 |
| Market
Cap: |
467.77(M) |
| Last
Volume: |
129,261 |
Avg
Vol: |
128,900 |
| 52
Week Range: |
$9.69 - $21.36 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Orthofix Medical is a medical device company. Co.'s Global Spine segment provides implantable medical devices, biologics, and other regenerative solutions. This segment's product categories include: Bone Growth Therapies, which manufactures, distributes, and provides support services for bone growth stimulation devices; Spinal Implants, which designs, develops and markets a portfolio of motion preservation and fixation implant products; and Biologics, which provides a portfolio of products and tissue forms. Co.'s Global Orthopedics segment provides products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,500 |
7,500 |
| Total Buy Value |
$0 |
$0 |
$101,025 |
$101,025 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
8,243 |
12,505 |
| Total Sell Value |
$0 |
$0 |
$156,617 |
$232,268 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
2 |
3 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Burzik Catherine M |
Director |
– • – |
2021-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,976 |
5,976 |
|
- |
|
| Hannon Jason |
Director |
– • – |
2021-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,313 |
9,431 |
|
- |
|
| Kenny Kevin J |
President of Global Spine |
• – – |
2020-12-04 |
4 |
D |
$37.09 |
$36,497 |
D/D |
(984) |
18,792 |
|
- |
|
| Serbousek Jon Carl |
CEO |
• • – |
2020-11-01 |
4 |
D |
$31.26 |
$45,827 |
D/D |
(1,466) |
74,181 |
|
- |
|
| Elting Kimberley A. |
Chief Legal & Develop. Officer |
• – – |
2020-09-26 |
4 |
D |
$29.40 |
$16,170 |
D/D |
(550) |
35,965 |
|
- |
|
| Gonsalves Paul |
President, Global Extremities |
• – – |
2020-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,624 |
10,624 |
|
- |
|
| Elting Kimberley A. |
Chief Legal & Develop. Officer |
• – – |
2020-09-05 |
4 |
D |
$28.79 |
$10,508 |
D/D |
(365) |
36,515 |
|
- |
|
| Serbousek Jon Carl |
CEO |
• • – |
2020-08-07 |
4 |
D |
$33.24 |
$29,816 |
D/D |
(897) |
75,647 |
|
- |
|
| Doug Rice |
CFO |
• – – |
2020-07-08 |
4 |
D |
$30.34 |
$44,175 |
D/D |
(1,456) |
55,706 |
|
- |
|
| Elting Kimberley A. |
Chief Legal & Admin Officer |
• – – |
2020-07-03 |
4 |
D |
$32.19 |
$11,138 |
D/D |
(346) |
36,880 |
|
- |
|
| Doug Rice |
CFO |
• – – |
2020-07-03 |
4 |
D |
$32.19 |
$12,007 |
D/D |
(373) |
57,162 |
|
- |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2020-07-03 |
4 |
D |
$32.19 |
$11,685 |
D/D |
(363) |
47,175 |
|
- |
|
| Doug Rice |
CFO |
• – – |
2020-07-01 |
4 |
D |
$32.34 |
$12,192 |
D/D |
(377) |
57,535 |
|
- |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2020-07-01 |
4 |
D |
$32.34 |
$12,774 |
D/D |
(395) |
47,538 |
|
- |
|
| Sicard John |
Director |
– • – |
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
10,919 |
|
- |
|
| Sainz Maria |
Director |
– • – |
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
40,871 |
|
- |
|
| Marks Lilly |
Director |
– • – |
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
25,794 |
|
- |
|
| Matricaria Ronald A |
Director |
– • – |
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,520 |
164,122 |
|
- |
|
| Lukianov Alexis V |
Director |
– • – |
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
16,083 |
|
- |
|
| Hinrichs James F. |
Director |
– • – |
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
50,514 |
|
- |
|
| Hannon Jason |
Director |
– • – |
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
4,588 |
|
- |
|
| Paolucci Michael E |
Director |
– • – |
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588 |
19,779 |
|
- |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2020-06-05 |
4 |
S |
$37.41 |
$327,323 |
D/D |
(8,750) |
47,933 |
|
8% |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2020-06-05 |
4 |
OE |
$21.78 |
$190,575 |
D/D |
8,750 |
56,683 |
|
- |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2020-04-02 |
4 |
D |
$26.66 |
$8,505 |
D/D |
(319) |
47,933 |
|
- |
|
697 Records found
|
|
Page 6 of 28 |
|
|
0.11 (0.84%) 
